Erythromycin and cyclosporine drug interaction. 1991

R J Ignoffo, and L E Kim
Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco 94143.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R J Ignoffo, and L E Kim
April 1988, Transplantation proceedings,
R J Ignoffo, and L E Kim
February 1986, The New England journal of medicine,
R J Ignoffo, and L E Kim
April 1987, Transplantation,
R J Ignoffo, and L E Kim
February 1987, Transplantation,
R J Ignoffo, and L E Kim
December 2016, British journal of clinical pharmacology,
R J Ignoffo, and L E Kim
September 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
R J Ignoffo, and L E Kim
September 1986, Annals of internal medicine,
R J Ignoffo, and L E Kim
June 1986, Transplantation,
R J Ignoffo, and L E Kim
April 2018, The primary care companion for CNS disorders,
R J Ignoffo, and L E Kim
October 1985, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!